Pharmacy Investment Opportunities in Cirebon

The company is a pharmaceutical distributor based in West Java, Indonesia, specializing in the distribution of generic pharmaceutical drugs. - Strong market presence: The company has a robust presence in the local market, serving over 200 clients, including Apotek pharmacies and hospitals in the region, which indicates a wide and established customer base. - Revenue performance: With an average monthly revenue of approximately 500 million, the company demonstrates consistent financial performance, reflecting its strong positioning and market demand for its products and services. - Government support: The company enjoys support from the government for its activities in the pharmaceutical industry, which could provide strategic advantages and potential regulatory benefits. - Exclusive supplier agreements: The company holds exclusive agreements with 105 pharmaceutical suppliers, indicating a competitive advantage and potentially favorable pricing and product availability. - Experience and expertise: With over 16 years in the industry, the company possesses extensive experience and expertise, signifying a deep understanding of the market and established relationships within the industry. - Local market focus: The company's focus on the local market in Indonesia provides a niche opportunity in serving the specific needs of the domestic pharmaceutical market, potentially leveraging local insights and relationships. - Sales drop: We saw a slight drop in our sales due to some issues with funding we did not have money to procure enough stock to reach expected sales. - We have all the required certifications to run.

The company is a pharmaceutical distributor based in West Java, Indonesia, specializing in the distribution of generic pharmaceutical drugs. - Strong market presence: The company has a robust presence in the local market, serving over 200 clients, including Apotek pharmacies and hospitals in the region, which indicates a wide and established customer base. - Revenue performance: With an average monthly revenue of approximately 500 million, the company demonstrates consistent financial performance, reflecting its strong positioning and market demand for its products and services. - Government support: The company enjoys support from the government for its activities in the pharmaceutical industry, which could provide strategic advantages and potential regulatory benefits. - Exclusive supplier agreements: The company holds exclusive agreements with 105 pharmaceutical suppliers, indicating a competitive advantage and potentially favorable pricing and product availability. - Experience and expertise: With over 16 years in the industry, the company possesses extensive experience and expertise, signifying a deep understanding of the market and established relationships within the industry. - Local market focus: The company's focus on the local market in Indonesia provides a niche opportunity in serving the specific needs of the domestic pharmaceutical market, potentially leveraging local insights and relationships. - Sales drop: We saw a slight drop in our sales due to some issues with funding we did not have money to procure enough stock to reach expected sales. - We have all the required certifications to run.